Mother-to-child transmission (MTCT) of Human T-cell lymphotropic virus type 1 (HTLV-1)
causes lifelong infection. At least 5–10 million individuals worldwide are currently living with …

Adult T-cell leukemia-lymphoma (ATL) is an aggressive T-cell malignancy caused by human
T-cell leukemia virus type 1 (HTLV-1) infection that often occurs in HTLV-1-endemic areas …

Immune checkpoint inhibitors are a powerful new tool in the treatment of cancer, with
prolonged responses in multiple diseases, including hematologic malignancies, such as …

Human T cell leukemia virus type 1 (HTLV-1), also known as human T lymphotropic virus
type 1, was the first exogenous human retrovirus discovered. Unlike the distantly related …

The African continent is considered the largest high endemic area for the oncogenic
retrovirus HTLV-1 with an estimated two to five million infected individuals. However, data on …

Going back to their discovery in the early 1980s, both the Human T-cell Leukemia virus type-
1 (HTLV-1) and the Human Immunodeficiency Virus type-1 (HIV-1) greatly fascinated the …

Human T-cell leukemia virus type I (HTLV-1)-associated myelopathy/tropical spastic
paraparesis (HAM/TSP) is a rare inflammatory disease causing unremitting and progressive …

The human T-lymphotropic virus type 1 (HTLV-1) retrovirus infects 10–20 million people
globally, with endemic regions in southwestern Japan, the Caribbean basin, Africa, and …

Abstract Background Bovine Leukemia Virus (BLV) is a deltaretrovirus closely related to the
Human T cell leukemia virus-1 (HTLV-1). Cattle are the natural host of BLV where it …

Human T-cell leukemia virus type I (HTLV-1) causes adult T-cell leukemia/lymphoma (ATL)
in 5% of infected people with a decades-long latency. Charles RM Bangham reviews the …